The study of the awareness and participation of pharmacists in the “Affordable Medicines” government program
DOI:
https://doi.org/10.24959/sphhcj.23.296Keywords:
“Affordable Medicines” program; reimbursement; arterial hypertension; antihypertensive drugs; e-prescriptions; pharmacist internship cycleAbstract
Aim. To study the awareness of pharmacists and their participation in the implementation of the “Affordable Medicines” government program when dispensing medicines for the treatment of arterial hypertension (AH); to determine directions for optimization of pharmaceutical care for dispensing medicines using electronic prescriptions (e-prescriptions) and improvement of training programs, thematic postgraduate cycles for pharmacists.
Materials and methods. The objects of analysis were 291 questionnaires on information support for pharmacists regarding dispensing of medicines for patients with AH during the implementation of the “Affordable Medicines” program. The questionnaires were filled out by pharmacists from 8 regions of Ukraine, they were studying at specialization courses, thematic postgraduate cycles in the period from December 2021 to December 2022. Such methods as questionnaires, Google-forms, generalization, content analysis were used.
Results. The analysis of the questionnaires showed that the largest percentage was pharmacists in the specialty “Organization and Management of Pharmacy”, who had more than 10 years of work experience. Among the surveyed pharmacists, 80 % work in pharmacies located in cities, which indicates an insufficient number of pharmacies and the implementation of the “Affordable Medicines” program in rural areas. According to the expert assessment, the following medicines are in the highest demand among hypertension patients using e-prescriptions: bisoprolol, enalapril, and clopidogrel, which are highly effective for the treatment of AH. It has been found that pharmacists consider it expedient to include new combined medicines and modern mono-preparations (perindopril, lisinopril, valsartan) in the Register; they are in demand among patients with AH at their own expense. It has been found that 96.3 % of pharmacists believe that it is necessary to receive more information support during the internship and thematic cycles on the pharmaceutical care for patients with AH according to evidence-based medicine, dispensing medicines according to e-prescriptions in the “Affordable Medicines” program in Ukraine.
Conclusions. The results of the expert assessment of pharmacists indicate that dispensing of medicines by e-prescriptions for patients with AH in the “Affordable Medicines” program has significantly improved the economic availability of medicines for outpatient treatment. It has been determined that it is advisable to expand this program with combined medicines and mono-preparations, which are in demand among patients at their own expense. The expediency of postgraduate educational programs has been substantiated, and methodical support has been prepared for thematic cycles, trainings on pharmaceutical care and e-prescriptions for AH.
References
Cardiovascular diseases (CVDs). World Health Organization (WHO). Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
Hypertension. World Health Organization (WHO). Available at: https://www.who.int/health-topics/hypertension/#tab=tab_1.
Cardiovascular diseases: A handbook for pharmacists. The Hague: International Pharmaceutical Federation. International Pharmaceutical Federation (FIP). 2022. Available at: https://www.fip.org/file/5251.
Dedet G., Polton D., Zimmermann N. et all. Evaluation of the “Affordable Medicines” program in Ukraine. Report WHO Regional office for Europe; 2019. 60 p. Available at: https://iris.who.int/handle/10665/346490.
Unifikovanyi klinichnyi protokol pervynnoi, ekstrenoi ta vtorynnoi (spetsializovanoi) medychnoi dopomohy. Arterialna Hipertenziia. Available at:https://www.dec.gov.ua/wp-content/uploads/2019/11/384_2012ykpmd_ag.pdf.
Arterialna hipertenziia. Onovlena ta adaptovana klinichna nastanova, zasnovana na dokazakh. Available at: https://www.dec.gov.ua/wp-content/uploads/2019/11/384_2012_kn_ag.pdf.
Pro zatverdzhennia Derzhavnoi stratehii realizatsii derzhavnoi polityky zabezpechennia naselennia likarskymy zasobamy na period do 2025 roku Postanova KMU vid 5 hrudnia 2018 No. 1022. Available at: https://zakon.rada.gov.ua/laws/show/1022-2018-%D0%BF#Text.
Nakaz MOZ Ukrainy vid 05.01.2022 No. 7 “Pro zatverdzhennia protokoliv farmatsevta”. Available at: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.dec.gov.ua/wp-content/uploads/2022/01/2022_7_nakaz_pf.pdf.
Pro zabezpechennia dostupnosti likarskykh zasobiv Postanova KMU vid 5 hrudnia 2018 No. 1022. Available at: https://zakon.rada.gov.ua/laws/show/152-2017-%D0%BF#Text.
Honchar, A. O., Sholoiko, O. V., Komarida, O. O. (2022). Reimbursatsiia kombinovanykh antyhipertenzyvnykh likarskykh zasobiv v Ukraini: aspekty yikh vkliuchennia ta zovnishnoho referentnoho tsinoutvorennia. Farmatsevtychnyi zhurna, 77, 6, 53-59. doi: 10.32352/0367-3057.6.22.06.
Malanchuk, N. V., Demchuk, M. B., Hroshovyi, T. A. (2022). Doslidzhennia asortymentu antyhipertenzyvnykh likarskykh zasobiv ta analiz yikh ekonomichnoi dostupnosti za umov realizatsii uriadovoi prohramy “Dostupni liky”. Farmatsevtychnyi chasopys. 4, 26–34. doi: 10.11603/2312-0967.2022.3.13540.
Nemchenko, A. S., Kurylenko, Yu. Ye., Nazarkina, V. M., Chernukha, V. M. 2020. Analiz stanu ta problem realizatsii derzhavnykh prohram iz dostupnosti likiv na osnovi anketuvannia medychnykh fakhivtsiv. Sotsialna farmatsiia v okhoroni zdorovia, 6, 4, 32-39. doi: 10.24959/sphhcj.20.198.
Huz, V. S., Zaliska, O. M., Maksymovych, N. M. (2021). Analiz tendentsii u prohrami reimbursatsii “Dostupni liky” v Ukraini. Farmatsevtychnyi chasopys. 4, 53–62. doi: 10.11603/2312-0967.2021.4.12658.
Khyts, A. R. (2020). ISH 2020: onovleni klinichni rekomendatsii, nova klasyfikatsiia arterialnoi hipertenzii ta sproshchena klasyfikatsiia kardiovaskuliarnoho ryzyku. Ukrainskyi medychnyi chasopys. Available at: www.umj.com.ua/uk/publikatsia-180785-ish-2020-onovleni-klinichni-rekomendatsiyi-nova-klasifikatsiya-arterialnoyi-gipertenziyi-ta-sproshhena-klasifikatsiya-kardiovaskulyarnogo-riziku.
Zaliska, O. M., Huz, V. S., Semenov, O. M., Maksymovych, N. M., Sichkoriz, O. Ie., Slabyi, M. V. (2020). Systema otsinky medychnykh tekhnolohii ta reimbursatsii, vidpusk za e-retseptamy likarskykh zasobiv dlia farmakoterapii arterialnoi hipertenzii v umovakh pandemii COVID-19 za danymy dokazovoi medytsyny : Metod. rek. Lviv : LNMU imeni Danyla Halytskoho.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
